Marketers of Health Supplement Settle FTC Deceptive Ad ChargesPDF
Peter Steinman's article, "Marketers of Health Supplement Settle FTC Deceptive Ad Charges," was published in DRMA Voice on November 8, 2016.
From the article...
"The Federal Trade Commission (FTC) recently announced a settlement with Supple LLC over charges that the manufacturer employed false advertising to promote its eponymous liquid health supplement, including that the product “provided complete relief from chronic and severe joint pain caused by arthritis and fibromyalgia and was scientifically proven to eliminate joint pain.” The defendant sold more than $150 million in supplements between 2011 and 2015, an amount that they are now forfeiting. The action serves as a reminder to marketers, particularly those that utilize direct response television extensively in their campaigns, to avoid making unsubstantiated medical claims when advertising a health product."